[1]
A. C. Grigorescu and L. M. Teodorescu, “Tirosyne Kinase Inhibithors (TKIs) in the Treatment of Non –Small Cell Lung Cancer (NSCLC), Practical Pharmacological Aspects”, J. Drug Delivery Ther., vol. 10, no. 1, pp. 135–138, Jan. 2020, doi: 10.22270/jddt.v10i1.3830.